Posttransplant skin cancer: A possible role for p53 gene mutation but not for oncogenic human papillomaviruses
- 31 May 1994
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 30 (5), 701-706
- https://doi.org/10.1016/s0190-9622(08)81498-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Evaluation of Human Papillomavirus Type 5 on Frozen Sections of Multiple Lesions from Transplant Recipients with in situ Hybridization and Non-lsotopic ProbesDermatology, 1992
- Presence of Human Papilloma Virus Type 16 DNA Sequences in Human Nonmelanoma Skin CancersJournal of Investigative Dermatology, 1991
- The p53 tumour suppressor geneNature, 1991
- Cutaneous squamous cell carcinomas and papillomaviruses in renal transplant recipients: A clinical and molecular biological studyJournal of Dermatological Science, 1991
- Occurrence of human papillomavirus type 16 DNA in cutaneous squamous and basal cell neoplasmsJournal of the American Academy of Dermatology, 1990
- Squamous cell carcinoma of the nail bed: a clinicopathological study of 12 casesBritish Journal of Dermatology, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Histopathology of skin lesions in renal allograft recipients—an assessment of viral features and dysplasiaHistopathology, 1989
- Distinctive epidermal atypia in immunosuppression‐associated cutaneous malignancyHistopathology, 1988